PH31669A - Bcrf1 proteins as inhibitors of interferon-gamma. - Google Patents

Bcrf1 proteins as inhibitors of interferon-gamma.

Info

Publication number: PH31669A
Authority: PH; Philippines
Prior art keywords: gamma; interferon; inhibitors; bcrf1; proteins
Prior art date: 1989-12-20

Application number

PH41744A

Other languages

English (en)

Inventor

Kevin W Moore

Robert A Kastelein

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-20

Filing date

1990-12-18

Publication date

1999-01-18

1990-12-18 Application filed by Schering Corp filed Critical Schering Corp

1999-01-18 Publication of PH31669A publication Critical patent/PH31669A/en

Links

102000008070 Interferon-gamma Human genes 0.000 title 1
108010074328 Interferon-gamma Proteins 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
229960003130 interferon gamma Drugs 0.000 title 1
102000004169 proteins and genes Human genes 0.000 title 1
108090000623 proteins and genes Proteins 0.000 title 1
101150067964 BcRF1 gene Proteins 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
230000007815 allergy Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
239000013604 expression vector Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/14—Lymphokine; related peptides
- Y10S930/141—Interleukin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Transplantation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

PH41744A 1989-12-20 1990-12-18 Bcrf1 proteins as inhibitors of interferon-gamma. PH31669A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US45393189A	1989-12-20	1989-12-20

Publications (1)

Publication Number	Publication Date
PH31669A true PH31669A (en)	1999-01-18

Family

ID=23802631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH41744A PH31669A (en)	1989-12-20	1990-12-18	Bcrf1 proteins as inhibitors of interferon-gamma.

Country Status (27)

Country	Link
US (2)	US5627155A (fr)
EP (1)	EP0506836B1 (fr)
JP (1)	JP2648236B2 (fr)
KR (1)	KR960015199B1 (fr)
CN (1)	CN1057012C (fr)
AT (1)	ATE112317T1 (fr)
AU (1)	AU7899694A (fr)
CA (1)	CA2071907C (fr)
CZ (1)	CZ283049B6 (fr)
DE (1)	DE69013011T2 (fr)
DK (1)	DK0506836T3 (fr)
ES (1)	ES2064082T3 (fr)
FI (1)	FI104883B (fr)
HK (1)	HK185396A (fr)
HU (1)	HU215909B (fr)
IE (1)	IE72203B1 (fr)
IL (1)	IL96715A0 (fr)
MX (1)	MX9203409A (fr)
MY (1)	MY107449A (fr)
NO (1)	NO305703B1 (fr)
NZ (1)	NZ236512A (fr)
OA (1)	OA09703A (fr)
PH (1)	PH31669A (fr)
PT (1)	PT96231B (fr)
SK (1)	SK279830B6 (fr)
WO (1)	WO1991009127A1 (fr)
ZA (1)	ZA9010188B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL94878A (en) *	1989-06-28	2003-01-12	Schering Corp	Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
CA2070416A1 (fr) *	1989-10-23	1991-04-24	Richard Ingram	Inhibiteurs polypeptidiques du gamma-interferon
DE69201128T2 (de) *	1991-01-16	1995-05-24	Schering Corp	Behandlung von neoplastischen krankenheiten mit interleukin-10.
US6106823A (en) *	1991-01-16	2000-08-22	Schering Corporation	Treatment of neoplastic disease with interleukin-10
DK0600970T3 (da) *	1991-08-06	2000-05-29	Schering Corp	Anvendelse af interleukin-10-analoger eller -antagonister til behandling af endotoksin- eller superantigeninduceret tokscit
US5833976A (en) *	1991-08-06	1998-11-10	Schering Corporation	Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
US6008327A (en)	1992-03-13	1999-12-28	Akzo Nobel, N.V.	Peptides and nucleic acid sequences related to the Epstein Barr virus
DE69332197T2 (de) *	1992-03-13	2003-04-17	Organon Teknika B.V., Boxtel	Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmenten
AU3801193A (en) *	1992-03-20	1993-10-21	Schering Corporation	Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
ATE207120T1 (de) *	1993-07-23	2001-11-15	Hans Prof Dr Wolf	Dna-sequenzen des epstein-barr virus kodierend für ein diagnostisch relevantes virus-hüllprotein,durch pcr erhaltene expressionsklone und verwendung dieses rekombinanten antigens in diagnostischen tests
US5616724A (en) *	1996-02-21	1997-04-01	Cephalon, Inc.	Fused pyrrolo[2,3-c]carbazole-6-ones
ATE413881T1 (de) *	1997-08-08	2008-11-15	Celmed Oncology Usa Inc	Verfahren und zubereitungen um resistenz gegen biologische oder chemische therapien zu überwinden
SG11201402490XA (en)	2011-11-23	2014-06-27	Amgen Inc	Methods of treatment using an antibody against interferon gamma
WO2022016509A1 (fr) *	2020-07-24	2022-01-27	阎忠扬	Procédé de criblage de médicament et utilisation de médicament dans le traitement du psoriasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3583564D1 (de) *	1984-08-23	1991-08-29	Hans Joachim Wolf	Dna-sequenzen des ebv-genoms, rekombinante dna-molekuele, verfahren zur herstellung von ebv-verwandten antigenen sowie diagnostische zusammensetzungen und pharmazeutische zusammensetzungen, die die genannten antigene enthalten.
US5256768A (en) *	1985-12-13	1993-10-26	The Johns Hopkins University	Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics

1990
- 1990-12-18 MX MX9203409A patent/MX9203409A/es unknown
- 1990-12-18 HU HU9202075A patent/HU215909B/hu not_active IP Right Cessation
- 1990-12-18 PH PH41744A patent/PH31669A/en unknown
- 1990-12-18 JP JP3502513A patent/JP2648236B2/ja not_active Expired - Fee Related
- 1990-12-18 AT AT91902258T patent/ATE112317T1/de not_active IP Right Cessation
- 1990-12-18 WO PCT/US1990/007288 patent/WO1991009127A1/fr not_active Ceased
- 1990-12-18 CZ CS906351A patent/CZ283049B6/cs not_active IP Right Cessation
- 1990-12-18 CA CA002071907A patent/CA2071907C/fr not_active Expired - Fee Related
- 1990-12-18 KR KR1019920701474A patent/KR960015199B1/ko not_active Expired - Fee Related
- 1990-12-18 NZ NZ236512A patent/NZ236512A/en unknown
- 1990-12-18 SK SK6351-90A patent/SK279830B6/sk unknown
- 1990-12-18 DK DK91902258.2T patent/DK0506836T3/da active
- 1990-12-18 ES ES91902258T patent/ES2064082T3/es not_active Expired - Lifetime
- 1990-12-18 IL IL96715A patent/IL96715A0/xx unknown
- 1990-12-18 EP EP91902258A patent/EP0506836B1/fr not_active Expired - Lifetime
- 1990-12-18 PT PT96231A patent/PT96231B/pt not_active IP Right Cessation
- 1990-12-18 DE DE69013011T patent/DE69013011T2/de not_active Expired - Fee Related
- 1990-12-18 ZA ZA9010188A patent/ZA9010188B/xx unknown
- 1990-12-19 CN CN90110079A patent/CN1057012C/zh not_active Expired - Fee Related
- 1990-12-19 IE IE458890A patent/IE72203B1/en not_active IP Right Cessation
- 1990-12-19 MY MYPI90002207A patent/MY107449A/en unknown
1992
- 1992-06-16 FI FI922770A patent/FI104883B/fi active
- 1992-06-19 NO NO922456A patent/NO305703B1/no not_active IP Right Cessation
- 1992-06-19 OA OA60232A patent/OA09703A/en unknown
1994
- 1994-11-23 AU AU78996/94A patent/AU7899694A/en not_active Abandoned
1995
- 1995-05-26 US US08/450,749 patent/US5627155A/en not_active Expired - Lifetime
- 1995-06-06 US US08/466,950 patent/US5736390A/en not_active Expired - Lifetime
1996
- 1996-01-03 HK HK185396A patent/HK185396A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH05503846A (ja)	1993-06-24
IL96715A0 (en)	1991-09-16
CA2071907C (fr)	2000-08-08
AU652732B2 (en)	1994-09-08
FI922770L (fi)	1992-06-16
WO1991009127A1 (fr)	1991-06-27
HK185396A (en)	1996-10-11
HU215909B (hu)	1999-03-29
PT96231B (pt)	1998-09-30
CN1057012C (zh)	2000-10-04
ATE112317T1 (de)	1994-10-15
SK635190A3 (en)	1999-04-13
KR960015199B1 (ko)	1996-11-01
NZ236512A (en)	1997-07-27
IE904588A1 (en)	1991-07-03
DE69013011T2 (de)	1995-02-23
CZ283049B6 (cs)	1997-12-17
EP0506836B1 (fr)	1994-09-28
JP2648236B2 (ja)	1997-08-27
OA09703A (en)	1993-08-30
AU7063691A (en)	1991-07-18
PT96231A (pt)	1991-09-30
NO922456D0 (no)	1992-06-19
CN1052608A (zh)	1991-07-03
ZA9010188B (en)	1991-08-28
CA2071907A1 (fr)	1991-06-21
AU7899694A (en)	1995-02-09
FI922770A0 (fi)	1992-06-16
DK0506836T3 (da)	1994-11-28
DE69013011D1 (de)	1994-11-03
HU9202075D0 (en)	1992-10-28
US5736390A (en)	1998-04-07
EP0506836A1 (fr)	1992-10-07
HUT65369A (en)	1994-05-02
ES2064082T3 (es)	1995-01-16
IE72203B1 (en)	1997-04-09
US5627155A (en)	1997-05-06
NO922456L (no)	1992-06-19
CZ635190A3 (en)	1997-09-17
SK279830B6 (sk)	1999-04-13
NO305703B1 (no)	1999-07-12
FI104883B (fi)	2000-04-28
MY107449A (en)	1995-12-31
MX9203409A (es)	1992-07-01

Publication	Publication Date	Title
EP0335901A4 (en)	1990-11-28	Methods and compositions for the treatment of non-ige-mediated diseases
OA09703A (en)	1993-08-30	bcrf1 proteins as inhibitors of interferon-gamma
ES8602768A1 (es)	1985-11-16	Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
CS414591A3 (en)	1992-12-16	Cytokinin synthesis inhibition factor, antagonists thereof and its use
IL119461A (en)	2000-02-29	4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
RO90639B (ro)	1987-01-31	Procedeu pentru prepararea tesutului uman activator de plasminogen
GR1002486B (el)	1996-12-09	Νεα κρυσταλλικη μορφη κυκλοσπορινης, μεθοδος παραγωγης της,φαρμακευτικες συνθεσεις περιεχουσες αυτη και η χρησις της.
DE69130679D1 (de)	1999-02-04	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
EP0249247A3 (fr)	1989-05-10	Dérivés de purine
AU634003B2 (en)	1993-02-11	4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
HU9201799D0 (en)	1992-08-28	New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
EP0273310A3 (fr)	1991-01-09	5-Aryl-3H-1,2,4-triazol-3-ones et leur emploi comme anticonvulsifs
TW372873B (en)	1999-11-01	A novel anti-neoplastic cytokine
MY103584A (en)	1993-08-28	8(alpha)-acylaminoergoline, its preparation and pharmaceutical compositions containing it
HUT39599A (en)	1986-10-29	Process for producing compositions stimulating growth of hair
WO1990010006A3 (fr)	1990-11-01	NOUVEAUX β-METHOXYACRYLATES, LEUR PRODUCTION ET LEUR UTILISATION
MX9405923A (es)	1998-07-31	Mejoras en proceso para humectar y suavizar la piel.